You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 2, July 9, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Colon Cancer
 •Surgical Interventions
 •Colorectal Surgery
 •Gastrointestinal Diseases
 •Alert me on articles by topic

Screening for Colorectal Cancer

Since this article does not have an abstract, we have provided the first 138 words of the full text and any section headings.

To the Editor: Drs Walsh and Terdiman1-2 reviewed the evidence on the efficacy of various screening tests for the prevention of colorectal cancer. Although the authors provided an extensive discussion of guiac-based FOBTs, they did not mention fecal immunochemical tests. However, a recent statement by the American Cancer Society's Colorectal Cancer Advisory Group supports the use of such tests.3 Similarly, a recent statement by the American Cancer Society concludes that "in comparison with guaiac-based tests for the detection of occult blood, immunochemical tests are more patient-friendly, and are likely to be equal or better in sensitivity and specificity."4

Immunochemical tests are specific for lower gastrointestinal tract bleeding,5 are not affected by diet or medications, engender greater patient participation, and provide a stable end point that can be read precisely.


AUTHOR INFORMATION
Financial Disclosure: Dr Schlackman is an employee of Enterix Inc, which manufactures immunochemical FOBTs.

Neil Schlackman, MD
Enterix Inc
Falmouth, Me

1. Walsh JME, Terdiman JP. Colorectal cancer screening: scientific review. JAMA. 2003;289:1288-1296. FREE FULL TEXT
2. Walsh JME, Terdiman JP. Colorectal cancer screening: clinical applications. JAMA. 2003;289:1297-1302. FREE FULL TEXT
3. Levin B, Brooks D, Smith RA, Stone A. Emerging technologies in screening for colorectal cancer. CA Cancer J Clin. 2003;53:44-55. FREE FULL TEXT
4. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin. 2003;53:27. FREE FULL TEXT
5. Rockey DC, Auslander A, Greenberg PD. Detection of upper gastrointestinal blood with fecal occult blood tests. Am J Gastroenterol. 1999;94:344-350. FULL TEXT | ISI | PUBMED

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2003;290:191.


RELATED ARTICLES

Screening for Colorectal Cancer
Gabriel E. Feldman, Colin W. McCord, Mary T. Bassett, and Thomas R. Frieden
JAMA. 2003;290(2):191.
EXTRACT | FULL TEXT  

Screening for Colorectal Cancer—Reply
Judith M. E. Walsh and Jonathan P. Terdiman
JAMA. 2003;290(2):192.
EXTRACT | FULL TEXT  

Colorectal Cancer Screening: Scientific Review
Judith M. E. Walsh and Jonathan P. Terdiman
JAMA. 2003;289(10):1288-1296.
ABSTRACT | FULL TEXT  

Colorectal Cancer Screening: Clinical Applications
Judith M. E. Walsh and Jonathan P. Terdiman
JAMA. 2003;289(10):1297-1302.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.